Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
11.96
28.13
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Zhejiang Jiuzhou Pharmaceutical Co Ltd stock under the Base Case scenario is 25.64 CNY. Compared to the current market price of 14.87 CNY, Zhejiang Jiuzhou Pharmaceutical Co Ltd is Undervalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Zhejiang Jiuzhou Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Balance Sheet Decomposition
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Current Assets | 6.4B |
Cash & Short-Term Investments | 2.8B |
Receivables | 1.5B |
Other Current Assets | 2B |
Non-Current Assets | 4.7B |
Long-Term Investments | 131.5m |
PP&E | 3.9B |
Intangibles | 675.4m |
Other Non-Current Assets | 8.9m |
Current Liabilities | 1.9B |
Accounts Payable | 867.2m |
Accrued Liabilities | 163.8m |
Short-Term Debt | 253.6m |
Other Current Liabilities | 643m |
Non-Current Liabilities | 798m |
Long-Term Debt | 431.6m |
Other Non-Current Liabilities | 366.4m |
Earnings Waterfall
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Revenue
|
5B
CNY
|
Cost of Revenue
|
-3.3B
CNY
|
Gross Profit
|
1.7B
CNY
|
Operating Expenses
|
-805m
CNY
|
Operating Income
|
938.6m
CNY
|
Other Expenses
|
-52m
CNY
|
Net Income
|
886.5m
CNY
|
Free Cash Flow Analysis
Zhejiang Jiuzhou Pharmaceutical Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Zhejiang Jiuzhou Pharmaceutical Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Zhejiang Jiuzhou Pharmaceutical Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Zhejiang Jiuzhou Pharmaceutical Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Score
Zhejiang Jiuzhou Pharmaceutical Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Zhejiang Jiuzhou Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Zhejiang Jiuzhou Pharmaceutical Co Ltd is 20.82 CNY with a low forecast of 18.89 CNY and a high forecast of 24.95 CNY.
Dividends
Current shareholder yield for Zhejiang Jiuzhou Pharmaceutical Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. engages in the production and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst and lithium battery materials. The company is headquartered in Taizhou, Zhejiang and currently employs 4,083 full-time employees. The company went IPO on 2014-10-10. is a China-based company principally engaged in the research, development, production and sales of chemical Active Pharmaceutical Ingredients (API) and intermediates. The firm mainly operates through two segments, including the New Drug and Intermediates Contract Development and Manufacturing Organization (CDMO) segment and the Specialty APIs and Intermediates segment. The New Drug and Intermediates CDMO segment mainly provides services for innovative medicines of pre-clinical chemical manufacturing and controls (CMC), clinical phases I, II and III, new drug application (NDA) and various stages after going public. The Specialty API and Intermediates segments mainly provides services including patent breakthroughs, production process improvement, drug certificate declaration, and cGMP standard commercial production for patented expired or soon-to-be-expired drugs for global chemical and generic drug manufacturers.
Contact
IPO
Employees
Officers
The intrinsic value of one Zhejiang Jiuzhou Pharmaceutical Co Ltd stock under the Base Case scenario is 25.64 CNY.
Compared to the current market price of 14.87 CNY, Zhejiang Jiuzhou Pharmaceutical Co Ltd is Undervalued by 42%.